As the most common malignant tumor of central nervous system, the incidence rate of glioma is about 5/100,000-8/100,000, and the 2-year survival rate of the most common GBM patients is only 27%, and the 5-year survival rate is less than 10%, which makes the difficulty of the treatment extremely high and attracts much attention. In 2021, the 18th meeting of the Central Committee for Comprehensively Deepening Reform proposed that “multidisciplinary diagnosis and treatment (MDT) model” be written into the “Opinions on Promoting the High-Quality Development of Public Hospitals” as an important part of the innovation of healthcare service model, which has been highly valued at the national level! Based on this, Chengdu High-Tech Medical Association and Sichuan Provincial People's Hospital will hold the “Gum” Flow Moment - Glioma MDT Standardized Diagnosis and Treatment Academic Conference on February 1, 2024 - July 30, 2024, which aims to improve the standardized diagnosis and treatment level of relevant clinical workers, set up a platform for professional academic exchanges, and jointly promote the development of glioma cause. This conference aims to improve the standardized diagnosis and treatment level of related clinical workers, build a platform for professional academic exchange, and jointly promote the development of glioma.